Hyamedix ApS: Financial statements 2018
CVR: 39177749
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Hyamedix ApS (CVR 39177749) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 953,788 and a net result of DKK 0. The profit margin was 0%. Equity in the 2018 report amounted to DKK 1,000. The solvency ratio was 0.1%.
- Revenue
- DKK 953,788
- Gross Profit
- DKK 353,187
- Profit/Loss
- DKK 0
- Equity
- DKK 1,000
- Total Assets
- DKK 1,034,056
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Hyamedix ApS has published its interim report for the period December 15, 2017 – December 31, 2017.
About Hyamedix ApS
Hyamedix ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Hyamedix IVS. The management consists of Michael Foldager Johansen, Birgit Fuhlendorff and Khadija Schwach-Abdellaoui. The board consists of Michael Foldager Johansen (chair), Jesper Ahlmann Funding Andersen and Khadija Schwach-Abdellaoui. The company's owners include Ginnerup Capital ApS, Vivida ApS and Ginkgo ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,843,335 and a net result of DKK -886,857 compared with DKK -1,370,702 the year before. Equity in the 2025 report amounted to DKK -10,060,273.